Quick Answer
AbbVie Inc. reported Stockholders Equity of -$3.27 billion for fiscal year 2025.
AbbVie Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$3.27B | -198.3% |
| 2024 | $3.33B | -67.9% |
| 2023 | $10.36B | -40.0% |
| 2022 | $17.25B | +12.0% |
| 2021 | $15.41B | +17.8% |
| 2020 | $13.08B | +260.0% |
| 2019 | -$8.17B | +3.2% |
| 2018 | -$8.45B | -265.7% |
| 2017 | $5.10B | +9.9% |
| 2016 | $4.64B | +17.5% |
| 2015 | $3.94B | +126.5% |
| 2014 | $1.74B | -61.2% |
| 2013 | $4.49B | +1383.4% |
| 2012 | -$350.00M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.64B | -143.8% | -1343.7% |
| June 30, 2025 | -$183.00M | -102.7% | -112.9% |
| March 31, 2025 | $1.42B | -82.3% | -57.3% |
| December 31, 2024 | $3.33B | -67.9% | -44.9% |
| September 30, 2024 | $6.03B | -50.1% | -11.0% |
| June 30, 2024 | $6.78B | -47.3% | -15.3% |
| March 31, 2024 | $8.01B | -39.7% | -22.7% |
| December 31, 2023 | $10.36B | -40.0% | -14.3% |
- AbbVie Inc. showed a decrease of -198.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, AbbVie Inc.’s stockholders equity has declined by 834.3% (from -$350.00 million to -$3.27 billion).
- The most recent figure is from AbbVie Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: